ClinicalTrials.gg
Drug

Mirabegron clinical trials

Also written YM178, Myrbetriq and Betmiga.

studies test it
141
open now
21
in phase 3
29
first study started
2002

How each study uses mirabegron is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the mirabegron studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Jun 2012 · MYRBETRIQ · NDA 202611 (FDA, Drugs@FDA)
European Union
20 Dec 2012 · Betmiga · EMEA/H/C/002388 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Mirabegron
108
Mirabegron 50 MG
12
Mirabegron 25 MG
5
Myrebtriq
5
Mirabegron 50mg
4

Brand

Myrbetriq
44
Betmiga
22
Betanis
12

Development codes

YM178
46
BR9006-2
1

In one entry with another drug

Given together, or one or the other

Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
2

Studies by the year they started

140 studies that test it; most in 2016 (12)

Studies that test mirabegron, by start year
YearStudies
20021
20031
20041
20051
20063
20071
200811
20099
20103
20112
20125
20136
201411
201511
201612
20177
20185
20192
20206
20219
202210
20237
20248
20253
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
37
Phase 2
30
Phase 3
29
Phase 4
38
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 59 · Other 82

Astellas Pharma Inc (33) · Astellas Pharma Europe B.V. (13) · Astellas Pharma Global Development, Inc. (5) · Far Eastern Memorial Hospital (4) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Cedars-Sinai Medical Center (3) · Astellas Pharma China, Inc. (3) · Philip Kern (3)

Often tested with

Tested in the same studies.

Solifenacin (19) · Tamsulosin (7) · Tolterodine (6) · Tadalafil (3) · Cholinergic Antagonists (2) · Estrogens (2) · Montelukast (1) · Propranolol (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8, 2 in phase 3

Studies that test mirabegron, phase 3 first.

Studies

Open first, then newest update. How each study uses mirabegron is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 141

See all 141 studies that test mirabegron →

Given beside what is tested · 6 — mirabegron is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with mirabegron

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call mirabegron · ClinicalTrials.gg INT005090

  • MeSH (NLM) C520025mirabegronConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) MVR3JL3B2VMIRABEGRONConfirmed FDA, NLM, Wikidata
  • RxNorm 1300786Confirmed FDA, Wikidata
  • Wikidata Q3702534mirabegronConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C90633MirabegronOne source FDA
  • DrugBank DB08893One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.